Starpharma Holdings Limited (SPHRY)
OTCMKTS
· Delayed Price · Currency is USD
0.6200
+0.0300 (5.08%)
Apr 24, 2025, 4:00 PM EDT
Starpharma Holdings Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Operating Revenue | 4.16 | 9.76 | 4.21 | 4.9 | 2.15 | 6.56 | Upgrade
|
| Other Revenue | - | - | 0.14 | 0.26 | 1.34 | 0.56 | Upgrade
|
| Revenue | 4.16 | 9.76 | 4.34 | 5.16 | 3.49 | 7.12 | Upgrade
|
| Revenue Growth (YoY) | -60.98% | 124.64% | -15.87% | 48.04% | -50.99% | 161.58% | Upgrade
|
| Cost of Revenue | 9.91 | 10.69 | 12.36 | 14.46 | 15.87 | 15.7 | Upgrade
|
| Gross Profit | -5.75 | -0.93 | -8.02 | -9.29 | -12.38 | -8.58 | Upgrade
|
| Selling, General & Admin | 6.78 | 7.24 | 7.62 | 6.86 | 7.35 | 6.1 | Upgrade
|
| Operating Expenses | 6.78 | 7.24 | 7.62 | 6.86 | 7.35 | 6.1 | Upgrade
|
| Operating Income | -12.52 | -8.17 | -15.64 | -16.15 | -19.73 | -14.68 | Upgrade
|
| Pretax Income | -12.52 | -8.17 | -15.64 | -16.15 | -19.73 | -14.68 | Upgrade
|
| Earnings From Continuing Operations | -12.52 | -8.17 | -15.64 | -16.15 | -19.73 | -14.68 | Upgrade
|
| Net Income | -12.52 | -8.17 | -15.64 | -16.15 | -19.73 | -14.68 | Upgrade
|
| Net Income to Common | -12.52 | -8.17 | -15.64 | -16.15 | -19.73 | -14.68 | Upgrade
|
| Shares Outstanding (Basic) | 414 | 411 | 409 | 407 | 397 | 372 | Upgrade
|
| Shares Outstanding (Diluted) | 414 | 411 | 409 | 407 | 397 | 372 | Upgrade
|
| Shares Change (YoY) | 0.96% | 0.59% | 0.53% | 2.53% | 6.62% | 0.25% | Upgrade
|
| EPS (Basic) | -0.03 | -0.02 | -0.04 | -0.04 | -0.05 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.03 | -0.02 | -0.04 | -0.04 | -0.05 | -0.04 | Upgrade
|
| Free Cash Flow | -11.18 | -7.07 | -14.93 | -14 | -15.05 | -10.9 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.02 | -0.04 | -0.03 | -0.04 | -0.03 | Upgrade
|
| Gross Margin | -138.24% | -9.52% | -184.57% | -180.05% | - | -120.63% | Upgrade
|
| Operating Margin | -301.18% | -83.69% | -360.07% | -312.94% | -565.87% | -206.30% | Upgrade
|
| Profit Margin | -301.18% | -83.69% | -360.07% | -312.94% | -565.87% | -206.30% | Upgrade
|
| Free Cash Flow Margin | -268.93% | -72.43% | -343.82% | -271.19% | -431.72% | -153.21% | Upgrade
|
| EBITDA | -12.24 | -7.85 | -15.25 | -15.8 | -19.43 | -14.4 | Upgrade
|
| EBITDA Margin | -294.30% | -80.45% | - | - | - | -202.43% | Upgrade
|
| D&A For EBITDA | 0.29 | 0.32 | 0.39 | 0.36 | 0.3 | 0.28 | Upgrade
|
| EBIT | -12.52 | -8.17 | -15.64 | -16.15 | -19.73 | -14.68 | Upgrade
|
| EBIT Margin | - | -83.69% | - | - | - | -206.30% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.